These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin. Zhao Y; He D; Stern R; Usatyuk PV; Spannhake EW; Salgia R; Natarajan V Cell Signal; 2007 Nov; 19(11):2329-38. PubMed ID: 17689924 [TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. He D; Su Y; Usatyuk PV; Spannhake EW; Kogut P; Solway J; Natarajan V; Zhao Y J Biol Chem; 2009 Sep; 284(36):24123-32. PubMed ID: 19586906 [TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. Zhao J; He D; Su Y; Berdyshev E; Chun J; Natarajan V; Zhao Y Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L547-56. PubMed ID: 21821728 [TBL] [Abstract][Full Text] [Related]
5. Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line. Nishimura Y; Takiguchi S; Ito S; Itoh K Int J Oncol; 2014 Feb; 44(2):412-26. PubMed ID: 24297483 [TBL] [Abstract][Full Text] [Related]
6. Claudin-4 is required for modulation of paracellular permeability by muscarinic acetylcholine receptor in epithelial cells. Cong X; Zhang Y; Li J; Mei M; Ding C; Xiang RL; Zhang LW; Wang Y; Wu LL; Yu GY J Cell Sci; 2015 Jun; 128(12):2271-86. PubMed ID: 25948584 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells. He D; Natarajan V; Stern R; Gorshkova IA; Solway J; Spannhake EW; Zhao Y Biochem J; 2008 May; 412(1):153-62. PubMed ID: 18294142 [TBL] [Abstract][Full Text] [Related]
8. c-Met inhibitors attenuate tumor growth of small cell hypercalcemic ovarian carcinoma (SCCOHT) populations. Otte A; Rauprich F; von der Ohe J; Yang Y; Kommoss F; Feuerhake F; Hillemanns P; Hass R Oncotarget; 2015 Oct; 6(31):31640-58. PubMed ID: 26436697 [TBL] [Abstract][Full Text] [Related]
9. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy. Brevet M; Shimizu S; Bott MJ; Shukla N; Zhou Q; Olshen AB; Rusch V; Ladanyi M J Thorac Oncol; 2011 May; 6(5):864-74. PubMed ID: 21774103 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of Mer receptor tyrosine kinase signaling attenuated lipopolysaccharide-induced lung inflammation. Choi JY; Park HJ; Lee YJ; Byun J; Youn YS; Choi JH; Woo SY; Kang JL J Pharmacol Exp Ther; 2013 Feb; 344(2):447-58. PubMed ID: 23197771 [TBL] [Abstract][Full Text] [Related]
11. Cross-talk between lysophosphatidic acid receptor 1 and tropomyosin receptor kinase A promotes lung epithelial cell migration. Nan L; Wei J; Jacko AM; Culley MK; Zhao J; Natarajan V; Ma H; Zhao Y Biochim Biophys Acta; 2016 Feb; 1863(2):229-35. PubMed ID: 26597701 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of human lung epithelial and endothelial barrier function by thrombin. Kawkitinarong K; Linz-McGillem L; Birukov KG; Garcia JG Am J Respir Cell Mol Biol; 2004 Nov; 31(5):517-27. PubMed ID: 15284075 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid increases soluble ST2 expression in mouse lung and human bronchial epithelial cells. Zhao J; Chen Q; Li H; Myerburg M; Spannhake EW; Natarajan V; Zhao Y Cell Signal; 2012 Jan; 24(1):77-85. PubMed ID: 21871564 [TBL] [Abstract][Full Text] [Related]
14. A selective small molecule inhibitor of c-Met, PHA-665752, reverses lung premalignancy induced by mutant K-ras. Yang Y; Wislez M; Fujimoto N; Prudkin L; Izzo JG; Uno F; Ji L; Hanna AE; Langley RR; Liu D; Johnson FM; Wistuba I; Kurie JM Mol Cancer Ther; 2008 Apr; 7(4):952-60. PubMed ID: 18413809 [TBL] [Abstract][Full Text] [Related]
15. Autotaxin induces lung epithelial cell migration through lysoPLD activity-dependent and -independent pathways. Zhao J; He D; Berdyshev E; Zhong M; Salgia R; Morris AJ; Smyth SS; Natarajan V; Zhao Y Biochem J; 2011 Oct; 439(1):45-55. PubMed ID: 21696367 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613 [TBL] [Abstract][Full Text] [Related]
17. Tumor cell-derived Timp-1 is necessary for maintaining metastasis-promoting Met-signaling via inhibition of Adam-10. Schelter F; Grandl M; Seubert B; Schaten S; Hauser S; Gerg M; Boccaccio C; Comoglio P; Krüger A Clin Exp Metastasis; 2011 Dec; 28(8):793-802. PubMed ID: 21789719 [TBL] [Abstract][Full Text] [Related]
18. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions. Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232 [TBL] [Abstract][Full Text] [Related]
19. Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase. Machide M; Hashigasako A; Matsumoto K; Nakamura T J Biol Chem; 2006 Mar; 281(13):8765-72. PubMed ID: 16415345 [TBL] [Abstract][Full Text] [Related]
20. MET increases the sensitivity of gefitinib-resistant cells to SN-38, an active metabolite of irinotecan, by up-regulating the topoisomerase I activity. Sakai A; Kasahara K; Ohmori T; Kimura H; Sone T; Fujimura M; Nakao S J Thorac Oncol; 2012 Sep; 7(9):1337-44. PubMed ID: 22722827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]